Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients
2017 · Biotechnology Reports · 17 citations
https://doi.org/10.1016/j.btre.2017.05.002
R
Richard Straube
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
4.0K
Citations
20
h-index
33
i10-index
Richard Straube is an academic researcher from Soligenix (United States). The author has contributed to research in topics: Neonatal Respiratory Health Research & Respiratory Support and Mechanisms & Sepsis Diagnosis and Treatment. The author has an h-index of 20, co-authored 58 publications.
ORCID: 0009-0000-6257-6775Papers by this author
worksPrecision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis
2022 · Hormone and Metabolic Research · 11 citations
https://doi.org/10.1055/a-1776-7943
A-182 Phase 2a Study of Topical 0.25% Hypericin in Mycosis Fungoides: Results and Review of the FLASH Study
2024 · European Journal of Cancer · 0 citations
https://doi.org/10.1016/j.ejca.2024.114399
Neutrophil Extracellular Traps (NETs) as a Potential Target for Anti-Aging: Role of Therapeutic Apheresis
2025 · Universität Zürich, ZORA · 0 citations
https://doi.org/10.5167/uzh-291847
Therapeutic apheresis: A promising method to remove microplastics?
2025 · Universität Zürich, ZORA · 0 citations
https://doi.org/10.5167/uzh-292281
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat